Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Gossamer Bio Q2 EPS $(0.74) Up From $(0.80) YoY

Gossamer Bio Q2 EPS $(0.74) Up From $(0.80) YoY

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.74) per share. This is a 7.5 percent increase over losses of $(0.80) per share from the same period last year.

byBenzinga Newsdesk

August 9, 2022

1 minute read

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.74) per share. This is a 7.5 percent increase over losses of $(0.80) per share from the same period last year.

Energy Recovery Awarded Over $12.6M In SWRO Contracts In North Africa

By Benzinga Newsdesk

September 1, 8:04 AM

Energy Recovery, Inc. (NASDAQ:ERII)today announced a slate of contract awards totaling more than $12.6 million to supply its PX® Pressure Exchanger® energy recovery devices (PX) to

ERII

News

Home Depot Executive Saw Growth With Both Pro And Diy Customers In Q2, And Are Encouraged That Project Backlogs Remain Healthy

By Benzinga Newsdesk

August 16, 9:14 AM

- Reuters

electroCore Expands Intellectual Property Portfolio; The Two Patents Were Issued On December 26, 2023, And Relate To ElectroCore’s Non-Invasive Vagus Nerve Stimulation Technology

By Happy Mohamed

December 26, 9:04 AM

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO).

ECOR